Form 4 for HCAT Health Catalyst, Inc.
Accepted 2022-04-21 00:00:00 ET · period of report 2022-04-18 · accession 0001562180-22-003506 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-21 | 2022-04-18 | HCAT | Llewelyn Linda | CHRO | S - Sale | $22.59 | -2,039 | 62.2K | -3% | -$46.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-18 | S | D | 200 | $23.21 | 62,033 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-18 | S | D | 1,839 | $22.52 | 62,233 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $22.14 to $22.92 per share, inclusive. The Reporting Person will provide, upon request by the Issuer, a security holder of the Issuer, or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |